Argentum Falters Again On Gilenya As US Supreme Court Says No
Federal Circuit Told Argentum It Lacked Standing To Appeal
Argentum had argued that joint ventures "have become the norm and indeed part of the very fabric of the pharma industry." • Source: Shutterstock 
